Analysis of Animal Healthcare

Animal healthcare or veterinary drug products are substances designed for animals, excluding humans, including drugs used in animal feeds. The global animal healthcare market has witnessed significant growth in recent years, driven by various factors such as rising animal health expenditure, increasing prevalence of diseases in animals, concerns over zoonoses, initiatives by key companies, and the trend of pet humanization. Below, we will provide a detailed analysis of the current animal healthcare landscape and market.

Market Resilience During the COVID-19 Pandemic

The animal healthcare market has demonstrated remarkable resilience in the face of the COVID-19 pandemic. While the pandemic presented several challenges, such as decreased sales, disruptions in the supply chain and distribution, low demand and purchasing rates, and operational hurdles due to changing regulations worldwide, the market remained stable. This resilience can be attributed to several factors. Firstly, the surge in pet adoption during lockdowns and quarantine periods boosted the demand for animal health products and services.

Moreover, the trend of pet humanization, where pets are considered as family members and receive increased attention and care, further contributed to the stability of the market. Additionally, the growing concerns over zoonotic diseases, given the origins of the COVID-19 virus, highlighted the importance of animal health, leading to increased awareness and investment in this sector.

It’s also important to mention that the adoption of telemedicine and online channels like e-commerce as preferred distribution channels for purchasing vet products and pet food experienced significant growth during the pandemic.

The animal health market did encounter macroeconomic headwinds in the latter half of 2022. Factors like inflation, foreign exchange rate fluctuations, and geopolitical conflicts temporarily slowed down market growth. Major industry players, such as Zoetis, Elanco, and Vimian, experienced varying impacts on their revenue growth during this period. Nevertheless, the market is anticipated to bounce back in 2023 – 2024 and maintain its upward trajectory. The growing emphasis on animal health and the ongoing advancements in veterinary drugs and diagnostics present various opportunities for market expansion.

Pharmaceuticals and Veterinary Diagnostics

The consistent advancements in veterinary drugs, including anti-inflammatory drugs, parasiticides, antibiotics, and others, have contributed to pharmaceutical dominance in the animal healthcare industry. With trends such as pet humanization, pharmaceutical products are not only key in treating and preventing diseases in humans, but also animals. In addition to the consistent advancements, mergers and acquisitions are on the rise in the animal pharmaceutical industry and have opened up new growth opportunities, fostering more innovation and the development of novel therapies.

The veterinary diagnostics segment is also expected to witness significant growth in the coming years. Factors such as growing animal health expenditure, rising incidences of zoonotic diseases, and an increasing number of veterinary practitioners contribute to the expansion of this segment. Point-of-care diagnostics, including blood glucose monitors, pregnancy kits, and urinalysis strips, have gained popularity among pet owners due to their convenience and accessibility. However, food animal diagnostics remain confined to labs due to the high sensitivity and efficacy requirements in disease testing.

Future Growth Opportunities and Innovations

An opportunity for growth arises from the expanded production of animal-based food products. This increased production has the potential to significantly lower prices, making pet food more affordable and easily accessible. Additionally, advancements in veterinary healthcare technology, such as efficient information management systems and mobile technology, are expected to enhance the delivery of animal health services even further.

The growing emphasis on innovation in animal health has resulted in initiatives like the Innovative Medicines Initiative (IMI), a collaborative effort between public and private entities in Europe. The IMI aims to support research and development in veterinary pharmaceuticals, fostering innovation in the field. By accelerating the development and availability of innovative medicines for animals, the initiative plays a vital role in driving the growth and advancement of the animal health market.

Regional Insights: North America and Asia Pacific

North America dominates the animal health market, accounting for the largest revenue share in 2022. The region’s market leadership can be attributed to several factors, including government initiatives, technological advancements, rising awareness among pet owners, and a high disease burden. The presence of a well-established veterinary healthcare infrastructure and a significant number of pet owners who prioritize their pets’ health contribute to the region’s prominence in the market. Furthermore, ongoing advancements in veterinary drugs and diagnostics, coupled with favorable reimbursement policies, bolster the market growth in North America.

Asia Pacific, on the other hand, is expected to register a lucrative growth rate of about 10% during the forecast period. The region benefits from consistent research and development (R&D) investments by major players, commercialization of affordable therapeutics, and growing awareness of pet nutrition and supplies. Moreover, the rising disposable income, urbanization, and changing lifestyles in countries like China and India have resulted in an increased demand for animal health products and services.

Key Companies and Market Outlook

Major players in the animal health market have witnessed growth even during the pandemic. IDEXX, a leading provider of veterinary diagnostics and software solutions, reported a 12% increase in revenue, reflecting the resilience and potential of the industry. Other key players such as Zoetis, Elanco, and Vimian are also expected to continue driving innovation and contributing to the overall market growth. These companies focus on strategic initiatives (mergers and acquisitions), but also collaborations and product launches to expand their market presence and cater to the evolving needs of the animal health sector.


The global animal health market has experienced significant growth driven by various factors, and it continues to demonstrate resilience. The pharmaceutical and veterinary diagnostics segments play a crucial role in shaping the market landscape, and future growth opportunities arise from technological advancements and increased production of animal-based food products. Regional dynamics, with North America leading the market and Asia Pacific, exhibiting substantial growth potential, further contribute to the overall market expansion. 

As a primary market research company, FMR Global Health provides invaluable insights into the global animal health market. Our expertise and analysis empower industry players to make informed decisions, navigate challenges, and seize growth opportunities in this rapidly evolving sector. By understanding the driving factors, impacts of COVID-19, and future prospects of the animal health market, FMR Global Health helps shape the future of animal healthcare worldwide.

Related Read: Unlock the Secret to Identify Most Relevant Characteristics of Healthcare Products that Should be Focused on Communication Strategies.